share_log

Why Navidea Biopharmaceuticals Shares Are Nosediving

Benzinga ·  Jul 31, 2023 09:39

Navidea Biopharmaceuticals Inc (NASDAQ:NAVB) shares are trading lower by 18.5% to $0.08 after the company announced NYSE American has commenced delisting proceedings and the company intends to appeal.

Navidea's Board of Directors plans to appeal the decision. During the appeal, the common stock will continue to be listed and traded on NYSE American.

The company says there can be no assurance that Navidea's request for continued listing will be granted.

If delisted, Navidea intends to quote its common stock in the over-the-counter market.

See Also: Why AerCap Shares Are Rising Today

According to data from Benzinga Pro, NAVB has a 52-week high of $0.65 and a 52-week low of $0.07.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment